Therapix Biosciences Ltd. is expanding into precision medicine through a new fully-owned subsidiary in order to develop novel solutions for pain. This new subsidiary will complement the Company's cannabinoid-based drug development strategy. Therapix will elaborate on this additional strategic area of focus, with the goal of creating a full-circle.